Bob Ehrlich Talks with WSJ: New Drug Ads Tout Serious Conditions, Costly Treatments By Lily Stauffer on February 23, 2016 in DTC News Related Lily StaufferEditorial AssociateLily Stauffer serves as an Editorial Associate for DTC Perspectives. She is currently a senior at Saint Joseph's University, studying Pharmaceutical Marketing and Spanish.
No comments yet.